Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes. This is the next big piece. I'm surprised we haven't heard anything yet. However, PR firms delays releases quite a bit during the holidays m. My company is waiting until the new year for press releases that were ready in the 20th of dec.
Do the math... Dilution is not the answer
Nobody want to see additional shares issued. However, its not the end of the world. If they did issue 7m new shares. That's less than 1% ( hardly meaningful)
My company just issued 35 % new shares with virtually no dilution
That's because the quote they pulled was fun mid 2014 ... Before the name change.
This article is a medical journal not a stock promotion... If it were they would have reference the name change and the ticker
Actually EMA is a bigger market and offer more financial assistance and longer exclusivity. Not that it matters much
That was for the October 6-8th meeting. PMCB was not even on the agenda.
Hope you all bought yesterday... IMO Big jump today
Only if you sold it. In 6 months buying at 10 cents or 8 cents won't make much of a difference
Can anyone name another drug delivery platform?
This is very rare what Pmcb is doing.
Patent terms have de facto extensions do to regulatory processes taking so long.
More than you want to know
http://jolt.law.harvard.edu/articles/pdf/v26/26HarvJLTech403.pdf
Wow... This board has degraded so much.
Entertainment only... Haven't seen anything meaningful in a long time. All bs back and forth... Like children
Yes. Obviously
SA used to be a good source 5 years ago... Now they do not have the over site they used to. No better than a message board
Big day tomorrow imho... Hopefully Pmcb follows up the exposure with the news we have been waiting for
This is very typical to have the sec comment on statements made.
My last company that I took public hd 5 rounds of comments from the sec prior to us being allowed to file our S1. Typically there are 50-60 SEC comments the first round and there are usually 3-5 rounds of comments until the SEC is satisfied
Anyone on this board holding more than 1/2 million shares? (~10 bps of shares outstanding) Just curious
I disagree... They care simply applying the scientific method (single variable testing) to optimize. First the variable was number of cells... No that that has been optimized they are doing the same with the dosage.
I think I was seeking from weak or short hands.... People who were expecting results to be shared sooner than is reasonable
"This study is being done to determine the most appropriate minimal dose of ifosfamide to use in combination with Cell-in-a-Box® for the treatment of malignant ascites fluid using the ES-2 tumor model system. PharmaCyte Biotech expects that its timetable to commence a Phase 1 clinical trial to treat the accumulation of malignant ascites fluid will not be affected by this new study."
Looks like the mm don't want pps to cross .16 ... Most likely hoping for a dip to cover
What company?
Think u misunderstood. I meant there are to sides to Pmcb . The alpha article is clearly one sided...any article that is clearly this onesided clearly has an adgenda
There are two sides to this. This post was completely onesided.
It's True they have no revenue...
.... But that's because they are still in the testing phase ...
Yes there is risk that the product won't come to market...
.... But that's why the pps is only .2 and the risk is lessened by multiple irons in the fire.
Yes it's true that the have spent very little corporate expenses on r&d
.... But that is because the are past the development stage and into testing the design for which is being done by the CRO
Etc...
A good article would tell both sides best as possible and let the reader decide their opinion. Anything else is an article with an agenda one way or the other
Because the market isn't open yet so trades don't get executed
Journal Article from national cancer institute
http://m.jnci.oxfordjournals.org/content/106/12/dju417.full
Rhee is a lot that is undisclosed due to the confidentiality agreement. The withdrawal ...speculative could be a good thing. For example if they have been negotiating a partnership or buyout
Not directed toward anyone specifically. I believe this company is still a long way from establishing itself (2 years) a year ago I would have said 4 years.
If anyone is looking for a long return before 2017, I think it is a mistake. The price will be manipulated an will trade on news until it has solid footing.
Further more I have seen a lot of selling at peaks which signals that this stock is being traded more than held. IMHO there is money to be made from trading now but more and more shareholders will be holding moving forward
If u are long and watching this stock every day is crazy (for any other purpose but to buy more)
You have made your investment and done your dd. hopefully u have not bet more than u can lose. This is a long play (years) it will fluctuate maybe fall to .10 at some point, but in two years .30 will be long gone in my opinion
Seeking alpha article bashing nvlx was from a company with a large short interest... Again
http://www.hotstocked.com/article/88895/nuvilex-inc-otcmkts-nvlx-gets-bashed-down-by.html
Seeking alpha released another hatchet job article on nvlx today.
Release of decision is not immediate
Nope... It's an OTC stock... Price gets driven down for big investors to get in at a discount. Decision has not yet been made... It's all speculation now.
God go back up 30% in a free days... Penny stocks are volitale
That submitted on sept2 ... Check out the ema website... It's omnipotent the comp agenda
I bought another 20k at .227 ... If it goes lower in the short term I don't mind... May buy more. I am buying because of where I think the price will be more than 3 years out
13 I'm averaging .18 with ~ 300 shares